Oramed Pharmaceuticals (ORMP) Other Working Capital Changes (2022 - 2026)
Oramed Pharmaceuticals (ORMP) posted Other Working Capital Changes of -$2.0 million for Q1 2026, down 194.47% on a QoQ basis from $2.1 million in Q4 2025, and down 200100.0% year-over-year from N/an in Q1 2025.
Oramed Pharmaceuticals (ORMP) Other Working Capital Changes (2022 - 2026) Analysis & Trends
Oramed Pharmaceuticals' Other Working Capital Changes history runs 5 years deep, the most recent figure standing at -$2.0 million for Q1 2026.
- Quarterly Other Working Capital Changes fell 200100.0% year-over-year to -$2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.9 million (down 4695.12% YoY) and the FY2025 annual result came in at $117000.0, up 172.09% from the prior year.
- Other Working Capital Changes was -$2.0 million for Q1 2026 at Oramed Pharmaceuticals, down from $2.1 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $1.3 million in Q4 2025 and bottomed at -$674000.0 in Q2 2022.
- A 5-year average of -$11588.2 and a median of -$59000.0 in 2024 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2025 — Other Working Capital Changes soared 14013.33% — and 2026, when it sank 200100.0%.
- Oramed Pharmaceuticals' Other Working Capital Changes stood at -$70000.0 in 2022, then sank by 1778.57% to -$1.3 million in 2023, then soared by 101.14% to $15000.0 in 2024, then surged by 14013.33% to $2.1 million in 2025, then slumped by 194.47% to -$2.0 million in 2026.
- Business Quant data shows ORMP's Other Working Capital Changes at -$2.0 million in Q1 2026, $2.1 million in Q4 2025, and -$2.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Oramed Pharmaceuticals | 170.25 Mn | 170.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.00 Mn |
| Mar 31, 2026 | -2.00 Mn |
| Mar 31, 2026 | -2.00 Mn |
| Dec 31, 2025 | 2.12 Mn |
| Dec 31, 2025 | 2.12 Mn |
| Dec 31, 2025 | 2.12 Mn |
| Jun 30, 2025 | -2.00 Mn |
| Jun 30, 2025 | -2.00 Mn |
| Jun 30, 2025 | -2.00 Mn |
| Mar 31, 2025 | 1,000.00 |
| Mar 31, 2025 | 1,000.00 |
| Mar 31, 2025 | 1,000.00 |
| Dec 31, 2024 | 15,000.00 |
| Dec 31, 2024 | 15,000.00 |
| Dec 31, 2024 | 15,000.00 |
| Sep 30, 2024 | 23,000.00 |
| Sep 30, 2024 | 23,000.00 |
| Sep 30, 2024 | 23,000.00 |
| Jun 30, 2024 | 2,000.00 |
| Jun 30, 2024 | 2,000.00 |